Skip to Content

Genes Controlled with Light

Scientists have found a way to use light to control blood sugar in mice.
June 23, 2011

Using a protein from the human retina, researchers in Switzerland have developed a method to control the expression of target genes with light. The scientists say the technology could be employed in the near term to boost the production of biological drugs, such as those for cancer, by enabling precise control over protein production. In the long term, cells engineered to carry the light-sensitive switch could be implanted into patients to produce a missing hormone, such as insulin, on demand.

Power of light: These diabetic mice have been implanted with cells genetically engineered to trigger insulin production when exposed to blue light.

Martin Fussenegger and collaborators at the Swiss Federal Institute for Technology engineered cells to carry the gene for a light-sensitive protein from the human retina, called melanopsin, which triggers a surge in calcium inside the cell when exposed to light. That calcium surge activates a second component, a protein that can be linked to any gene of interest. Shining light on the cells triggers the calcium, which activates the protein, thereby turning on the target gene. According to experiments in cultured cells, the timing and intensity of light controls both the amount and timing of the gene produced.

Researchers demonstrated the technology by implanting light-controlled cells into diabetic mice and using light to manipulate the animals’ insulin levels. When the cells were implanted just beneath the skin, exposure to blue light triggered insulin production. In a second experiment, researchers encapsulated the cells in a porous material and implanted them more deeply into the body, along with a fiber-optic cable to deliver light when needed. Both methods were able to control the animals’ blood sugar. The research was published today in the journal Science.

The Swiss research is the latest effort to control increasingly complex biological functions with light. Most of the research has focused on brain cells, and activating and silencing them through light-sensitive channels—a rapidly growing field known as optogenetics. But a handful of researchers are fusing optogenetics techniques with synthetic biology, an offshoot of molecular biology that attempts to engineer cells to perform useful functions. “There’s a growing interest in using light as a trigger for different biological pathways,” says James Collins, a biological engineer at Boston University. Light, unlike most chemical triggers, can be delivered “in a very localized way,” says Collins.

In addition to insulin, the technology can potentially deliver other types of therapeutic proteins, such as human growth hormone, Fusseneger says. Currently, these proteins are produced by engineered cells growing in a bioreactor, he says, and then delivered by injection or another method. “But now you could produce it in the patient and get the dosing right not by injection but by applying light.”

In fact, Fussenegger says, one of the near-term applications for the research is in biopharmaceutical manufacturing, the production of therapeutic proteins in bioreactors. Many such proteins are toxic to the cells in which they are grown, impeding production. But if protein production could be precisely controlled with light, researchers could grow the cells first and then activate production of the protein, tuning production on and off as needed to maintain the health of the cells.

Keep Reading

Most Popular

Workers disinfect the street outside Shijiazhuang Railway Station
Workers disinfect the street outside Shijiazhuang Railway Station

Why China is still obsessed with disinfecting everything

Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Europe's AI Act concept
Europe's AI Act concept

A quick guide to the most important AI law you’ve never heard of

The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.